Synoligo Biotechnologies
PrivateLast Round
Seed
Aug 1, 2022
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Synoligo Biotechnologies is a contract research and development organization (CRDO) that specializes in the manufacturing of complex and highly modified oligonucleotides for academic, biotech, and pharmaceutical sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synoligo Biotechnologies Comparables
Compare Synoligo Biotechnologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ADViRNA | 83% | |
| Bio-Synthesis, Inc. | 80% | |
| Microsynth AG | 73% | |
Synoligo Biotechnologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 1, 2022 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 187% MoM, reaching 8.4K.
- Aug 19, 2026
Grew 19% QoQ, from 36 to 43 employees.
Synoligo Biotechnologies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Synoligo Biotechnologies's valuation, stock price, and market status.